SP
Shabnum Patel
Stanford University, George Washington University, University of Washington & University of California, San Diego, University of California, Los Angeles
Research areas: Immunology and Microbiology · Immunology · CAR-T cell therapy research · T-cell and B-cell Immunology · Immunotherapy and Immune Responses
0000-0002-4782-9540
Employment
-
Stanford University School of Medicine PD and MFG Director2018 - Present
- 2017 - 2018
Education
-
University of Washington & University of California, San Diego Biotechnology Project Management Certificate2014 - 2015
-
George Washington University Ph.D. Microbiology & Immunology2012 - 2017
-
University of California Los Angeles B.S. Microbiology, Immunology, and Molecular Genetics2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial Save
- A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies Save
- CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma Save
- BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo Save
- Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer. Save
- Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders. Save
- HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals. Save
- Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma. Save
- HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths. Save
- A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae. Save
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. Save
- HIV-Specific T Cells from HIV Naive Adult and Cord Donors Target a Range of Novel Viral Epitopes - Implications for a Cure Strategy After Allogeneic Stem Cell Transplant Save
- Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood. Save
- Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy. Save
- T-cell therapies for HIV: Preclinical successes and current clinical strategies. Save
- HIV-Specific T Cells Can Be Expanded from Virus-Naive Donors to Target a Range of Viral Epitopes: Implications for a Cure Strategy After Allogeneic HSCT Save
- Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation. Save
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer Save
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer Save
- Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells Save